Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran

Antioxidants and Redox Signaling

Volumn 19, Issue 9, 2013, Pages 899-911

  Lu, Yuanyuan ^a   Zhao, Xiaodi ^a   Li, Kai ^a   Luo, Guanhong ^a   Nie, Yongzhan ^a   Shi, Yongquan ^a   Zhou, Yi ^a,b   Ren, Gui ^a   Feng, Bin ^a   Liu, Zhenxiong ^a   Pan, Yan ^a   Li, Ting ^a   Guo, Xuegang ^a   Wu, Kaichun ^a   Miranda Vizuete, Antonio ^c   Wang, Xin ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Tianjin Union Medical Centre   (China)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; RAN PROTEIN; THIOREDOXIN LIKE PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGE; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL INVASION; COLON CANCER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION;

ADULT; AGED; ALTERNATIVE SPLICING; CARRIER PROTEINS; CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENE ORDER; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; RAN GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84883350317     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4736     Document Type: Article

References (45)

1. Abe H, Kamai T, Shirataki H, Oyama T, Arai K, and Yoshida K. High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma. Int J Cancer 122: 2391-2397, 2008.
2. Almgren MA, Henriksson KC, Fujimoto J, and Chang CL. Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma. Mol Cancer Res 2: 387-394, 2004.
3. Barres V, Ouellet V, Lafontaine J, Tonin PN, Provencher DM, and Mes-Masson AM. An essential role for Ran GTPase in epithelial ovarian cancer cell survival. Mol Cancer 9: 272, 2010.
4. Bilitou A, Watson J, Gartner A, and Ohnuma S. The NM23 family in development. Mol Cell Biochem 329: 17-33, 2009.
5. Boissan M, Dabernat S, Peuchant E, Schlattner U, Lascu I, and Lacombe ML. The mammalian Nm23/NDPK family: from metastasis control to cilia movement. Mol Cell Biochem 329: 51-62, 2009.
6. Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, and Cheng C. CD44 splice isoform switching in human and mouse epithelium is essential for epithelialmesenchymal transition and breast cancer progression. J Clin Invest 121: 1064-1074, 2011.
7. Center MM, Jemal A, Smith RA, and Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 59: 366-378, 2009.
8. Chakraborti S, Mandal M, Das S, Mandal A, and Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253: 269-285, 2003.
9. Christensen B, Klaning E, Nielsen MS, Andersen MH, and Sorensen ES. C-terminal modification of osteopontin inhibits interaction with the alphaVbeta3-integrin. J Biol Chem 287: 3788-3797, 2012.
10. Conery AR, Sever S and Harlow E. Nucleoside diphosphate kinase Nm23-H1 regulates chromosomal stability by activating the GTPase dynamin during cytokinesis. Proc Natl Acad Sci USA 107: 15461-15466, 2010.
11. Deschoolmeester V, Baay M, Specenier P, Lardon F, and Vermorken JB. A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist 15: 699-731, 2010.
12. Fan H, Lu Y, Qin H, Zhou Y, Gu Y, Zhou J, Wang X, and Fan D. High Ran level is correlated with poor prognosis in patients with colorectal cancer. Int J Clin Oncol 2012. [Epub ahead of print]; DOI: 10.1007/s10147-012-0465-x.
13. Farina AR, Tacconelli A, Cappabianca L, Masciulli MP, Holmgren A, Beckett GJ, Gulino A, and Mackay AR. Thioredoxin alters the matrix metalloproteinase/ tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion. Eur J Biochem 268: 405-413, 2001.
14. Gialeli C, Theocharis AD and Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278: 16-27, 2011.
15. Hall A. The cytoskeleton and cancer. Cancer Metastasis Rev 28: 5-14, 2009.
16. Hartsough MT, Morrison DK, Salerno M, Palmieri D, Ouatas T, Mair M, Patrick J, and Steeg PS. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 277: 32389-32399, 2002.
17. Heo J. Redox control of GTPases: from molecular mechanisms to functional significance in health and disease. Antioxid Redox Signal 14: 689-724, 2011.
18. Heo J. Redox regulation of Ran GTPase. Biochem Biophys Res Commun 376: 568-572, 2008.
19. Kubens BS and Zanker KS. Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). Cancer Lett 131: 55-64, 1998.
20. Kurisetty VV, Johnston PG, Johnston N, Erwin P, Crowe P, Fernig DG, Campbell FC, Anderson IP, Rudland PS, and El-Tanani MK. RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin. Oncogene 27: 7139-7149, 2008.
21. Lee MJ, Xu DY, Li H, Yu GR, Leem SH, Chu IS, Kim IH, and Kim DG. Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma. Exp Mol Med 44: 214-224, 2012.
22. Li F, Hu G, Jiang Z, Guo J, Wang K, Ouyang K, Wen D, Zhu M, Liang J, Qin X, and Zhang L. Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells. FEBS J 279: 1261-1273, 2012.
23. Lillig CH and Holmgren A. Thioredoxin and related molecules-from biology to health and disease. Antioxid Redox Signal 9: 25-47, 2007.
24. Lim SH, Zhang Y and Zhang J. Cancer-testis antigens: the current status on antigen regulation and potential clinical use. Am J Blood Res 2: 29-35, 2012.
25. Lu Y, Wang X, Liu Z, Jin B, Chu D, Zhai H, Zhang F, Li K, Ren G, Miranda-Vizuete A, Guo X, and Fan D. Identification and distribution of thioredoxin-like 2 as the antigen for the monoclonal antibody MC3 specific to colorectal cancer. Proteomics 8: 2220-2229, 2008.
26. Ly TK, Wang J, Pereira R, Rojas KS, Peng X, Feng Q, Cerione RA, and Wilson KF. Activation of the Ran GTPase is subject to growth factor regulation and can give rise to cellular transformation. J Biol Chem 285: 5815-5826, 2010.
27. Meng F, Liu L, Chin PC, and D'Mello SR. Akt is a downstream target of NF-kappa B. J Biol Chem 277: 29674-29680, 2002.
28. Miyamoto M, Iwashita S, Yamaguchi S, and Ono Y. Role of nm23 in the regulation of cell shape and migration via Rho family GTPase signals. Mol Cell Biochem 329: 175-179, 2009.
29. Mook OR, Frederiks WM and Van Noorden CJ. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69-89, 2004.
30. Noike T, Miwa S, Soeda J, Kobayashi A, and Miyagawa S. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer. Hum Pathol 39: 201-208, 2008.
31. Oh JH, Chung AS, Steinbrenner H, Sies H, and Brenneisen P. Thioredoxin secreted upon ultraviolet A irradiation modulates activities of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in human dermal fibroblasts. Arch Biochem Biophys 423: 218-226, 2004.
32. Pajares MJ, Ezponda T, Catena R, Calvo A, Pio R, and Montuenga LM. Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 8: 349-357, 2007.
33. Qu Y, Wang J, Ray PS, Guo H, Huang J, Shin-Sim M, Bukoye BA, Liu B, Lee AV, Lin X, Huang P, Martens JW, Giuliano AE, Zhang N, Cheng NH, and Cui X. Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis andNF-kappaB signaling. J Clin Invest 121: 212-225, 2011.
34. Renault L, Kuhlmann J, Henkel A, and Wittinghofer A. Structural basis for guanine nucleotide exchange on Ran by the regulator of chromosome condensation (RCC1). Cell 105: 245-255, 2001.
35. Rensen WM, Mangiacasale R, Ciciarello M, and Lavia P. The GTPase Ran: regulation of cell life and potential roles in cell transformation. Front Biosci 13: 4097-4121, 2008.
36. Rundlof AK, Fernandes AP, Selenius M, Babic M, Shariatgorji M, Nilsonne G, Ilag LL, Dobra K, and Bjornstedt M. Quantification of alternative mRNA species and identification of thioredoxin reductase 1 isoforms in human tumor cells. Differentiation 75: 123-132, 2007.
37. Sadek CM, Jimenez A, Damdimopoulos AE, Kieselbach T, Nord M, Gustafsson JA, Spyrou G, Davis EC, Oko R, van der Hoorn FA, and Miranda-Vizuete A. Characterization of human thioredoxin-like 2. A novel microtubule-binding thioredoxin expressed predominantly in the cilia of lung airway epithelium and spermatid manchette and axoneme. J Biol Chem 278: 13133-13142, 2003.
38. Seifert M, Welter C, Mehraein Y, and Seitz G. Expression of the nm23 homologues nm23-H4, nm23-H6, and nm23-H7 in human gastric and colon cancer. J Pathol 205: 623-632, 2005.
39. Shlomai J. Redox control of protein-DNA interactions: from molecular mechanisms to significance in signal transduction, gene expression, and DNA replication. Antioxid Redox Signal 13: 1429-1476, 2010.
40. Sigrist CJ, Cerutti L, de Castro E, Langendijk-Genevaux PS, Bulliard V, Bairoch A, and Hulo N. PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res 38: D161-D166, 2010.
41. Speletas M, Argentou N, Karanikas V, Gramoustianou ES, Mandala E, Braimi M, Matsouka P, Ritis K, and Germenis AE. Survivin isoform expression patterns in CML patients correlate with resistance to imatinib and progression, but do not trigger cytolytic responses. Clin Immunol 139: 155-163, 2011.
42. Tseng YH, Vicent D, Zhu J, Niu Y, Adeyinka A, Moyers JS, Watson PH, and Kahn CR. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23. Cancer Res 61: 2071-2079, 2001.
43. Wang J, Zhou X, Cui L, Yan L, Liang J, Cheng X, Qiao L, Shi Y, Han Z, Cao Y, Han Y, and Fan D. The significance of CD14 + monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis. Cytotherapy 12: 1022-1034, 2010.
44. Zhang X, Jin B and Huang C. The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention. Curr Cancer Drug Targets 7: 305-316, 2007.
45. Zhou Q, Yang X, Zhu D, Ma L, Zhu W, Sun Z, and Yang Q. Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability. Biochem Biophys Res Commun 356: 348-353, 2007.